ASX - Delayed Quote AUD

Telix Pharmaceuticals Limited (TLX.AX)

26.62
-0.48
(-1.77%)
At close: 4:10:39 PM GMT+10

Research Analysis

Revenue vs. Earnings

Revenue 120.7M
Earnings --

Q3'22

Q4'22

Q2'23

0
20M
40M
60M
80M
100M
120M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

19.50 Low
32.05 Average
26.62 Current
36.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----44
Avg. Estimate 000.420.66
Low Estimate 000.330.56
High Estimate 000.510.79
Year Ago EPS ----0.170.42

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----99
Avg. Estimate ----1.28B1.62B
Low Estimate ----1.21B1.43B
High Estimate ----1.35B1.86B
Year Ago Sales ----783.21M1.28B
Sales Growth (year/est) ----62.81%27.34%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 000.420.66
7 Days Ago 000.390.7
30 Days Ago 000.390.72
60 Days Ago 000.390.72
90 Days Ago 000.360.51

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days ----1--
Up Last 30 Days ----11
Down Last 7 Days ----13
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
TLX.AX ----141.94%54.79%
S&P 500 12.66%3.22%7.99%13.82%

Related Tickers